Dacogen™ (Decitabine) For Injection –Updated ICD-9 Code

In the July 2006 newsletter, we provided notice of the FDA approval of Dacogen ™ (Decitabine) for injection for the treatment of MyeloDysplastic Syndrome (mds). Effective October 1, 2006, ICD-9 code 238.7 is invalid and is being replaced with ICD-9 codes 238.72-238.75. These new ICD-9 codes should be used for services rendered October 1, 2006 and after. Claims submitted with ICD-9 code 238.7 after October 1, 2006 will be rejected.

Effective January 1, 2007, HCPCS code J0894 has been assigned to use when billing for Dacogen ™ (injection, Decitabine, 1 mg). HCPCS code J9999 will not be appropriate to use as of January 1, 2007.